New-Generation Stent to Reduce Stenosis

The stent, called Disa S-Flex, has received the CE Mark of approval and preliminary clinical outcomes have shown good results.

Disa S-Flex was developed by Biomedical Engineering Company (BEC, Cape Town, South Africa) near the home of the world's first heart transplant. The stent was especially designed to minimize stenosis by reducing the degree of vessel-wall injury during and after stent implantation. The unique S-Flex linkage provides unusually high flexibility for easy delivery and low-injury vessel-wall conformity, while the eight-cell structure provides more circumferential support than existing six-cell stents. The developers believe this combination is the key to a less-restenotic implant.

Although a number of international distributorships have already been established by our distribution partner, Disa Vascular, this exciting development now allows us to rapidly expand our global marketing activities, said Dr. Gregory Starke, CEO of BEC. The company was founded by South African biomedical engineers in 1998.